VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 44 filers reported holding VIVEVE MED INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $352,000 | -63.1% | 917,973 | -7.1% | 0.02% | -57.4% |
Q1 2019 | $955,000 | +20.3% | 988,573 | +30.1% | 0.05% | +10.2% |
Q4 2018 | $794,000 | -41.4% | 760,056 | +48.9% | 0.05% | -25.8% |
Q3 2018 | $1,355,000 | +69.4% | 510,426 | +64.7% | 0.07% | +83.3% |
Q2 2018 | $800,000 | – | 310,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,849,711 | $10,471,000 | 6.36% |
RTW INVESTMENTS, LP | 2,861,023 | $7,782,000 | 0.56% |
Nantahala Capital Management | 3,948,132 | $10,739,000 | 0.44% |
Granahan Investment Management | 792,607 | $2,156,000 | 0.13% |
ACUTA CAPITAL PARTNERS, LLC | 267,500 | $728,000 | 0.13% |
KNOTT DAVID M | 71,449 | $194,000 | 0.07% |
WEXFORD CAPITAL LP | 349,100 | $950,000 | 0.06% |
HighTower Advisors, LLC | 1,821,456 | $4,957,000 | 0.04% |
MEITAV INVESTMENT HOUSE LTD | 310,000 | $800,000 | 0.04% |
J. Goldman & Co LP | 221,000 | $601,000 | 0.03% |